Expression of DYRK2 and REDK in hematopoietic tissues and cell lines
Tissue/Cells . | DYRK2 . | REDK . |
---|---|---|
Bone marrow | − | ++ |
Fetal liver | − | +++ |
PBLs | − | − |
Stroma | − | − |
TF274 | +++ | − |
Myeloid | − | − |
KG1a, HL60 | ||
Monocytic U937, THP-1 | − | − |
Erythroleukemic K562, HEL | − | ++ |
EPO-responsive UT7-EPO, TF1 | − | +++ |
Megakaryoblastic Mo7e, CMK | − | − |
Lymphocytic Bjab, Supt-1, Jurkat | ± | − |
Cancer lines | − | − |
A549, HeLa, MRC5 |
Tissue/Cells . | DYRK2 . | REDK . |
---|---|---|
Bone marrow | − | ++ |
Fetal liver | − | +++ |
PBLs | − | − |
Stroma | − | − |
TF274 | +++ | − |
Myeloid | − | − |
KG1a, HL60 | ||
Monocytic U937, THP-1 | − | − |
Erythroleukemic K562, HEL | − | ++ |
EPO-responsive UT7-EPO, TF1 | − | +++ |
Megakaryoblastic Mo7e, CMK | − | − |
Lymphocytic Bjab, Supt-1, Jurkat | ± | − |
Cancer lines | − | − |
A549, HeLa, MRC5 |
cDNA probes for DYRK2 and REDK were hybridized to dot blots containing equivalent amounts of pAK + RNA from the human tissues and cells shown. Signals above background were ranked as ±, +, ++, or +++.